Trial site
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
- 12running trials
- 4closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Myeloproliferative neoplasms2 trials
- Obesity2 trials
- Atrial fibrillation1 trial
- Dilated cardiomyopathy1 trial
- Gastric and oesophageal cancer1 trial
- Liver cirrhosis1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Not yet recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Karyopharm Therapeutics Inc2 trials
- Azienda Ospedaliera di Padova1 trial
- Azienda Ospedaliera Universitaria Integrata Verona1 trial
- Boston Scientific Corporation1 trial
- and 7 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
MIRAMACS, Multicenter Italian Study on RAdial Mechanically Assisted Circulatory Support
Recruiting
Recruiting
Active, not recruiting
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Active, not recruiting
Active, not recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Active, not recruiting
Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026